Home
Medical News
Lastet 10 Medical News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
FDA. New and Generic Drug Approvals - January 26, 2012
FDA. New and Generic Drug Approvals - January 25, 2012
FDA. New and Generic Drug Approvals - January 24, 2012
FDA. New and Generic Drug Approvals - January 23, 2012
FDA. New and Generic Drug Approvals - January 20, 2012
Dictionary
Browse alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
W
V
Y
Z
Drugs A-Z
Browse alphabetically Medicines Human:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Orfan Drugs
Browse alphabetically Supplements:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Wiew Veterinary medicines:
All Veterinary medicines
Health articles
Choose category
Herbal Articles
Toxic Substances A-Z Index
Parasitic Diseases
Mendeleev periodic table
Pharmaceutical companies
Medicinal plants list
EU Drugs
Cosmetics
Be eco! Be organic!
List of Vitamins
List of Minerals
Active substances and excipients
Medical Tests. Diagnostics
Health Organizations
Symptoms and signs of disease
List of Diseases
Drug manufacturers
Choose country
UK
Canada
USA
Denmark
Greece
Norway
Poland
Portugal
Germany
France
Japan
Brazil
Sweden
Italy
Spain
China
Argentina
Czech Republic
Hospitals Worldwide
Choose country
Australia
Brazil
Canada
India
Ireland
Israel
Malaysia
Mexico
Netherlands
Nigeria
Saudi Arabia
South Africa
Spain
Switzerland
USA
UK
Search drugs:
Home
-
Drugs and Supplements A-Z
Drugs and Sepplements. Supplements K
KAL B12 5000 mcg Timed Release, Nutraceutical Corp.
KAL B2 100 mg, Nutraceutical Corp.
KAL B50 Complex, Nutraceutical Corp.
KAL B6 100 mg Active TR 6, Nutraceutical Corp.
KAL B6 100 mg, Nutraceutical Corp.
KAL B6 50 mg, Nutraceutical Corp.
KAL B6 B12 Folic Acid Lozenge, Nutraceutical Corp.
KAL Bean Relief, Nutraceutical Corp.
KAL Beta Carotene 25,000 IU, Nutraceutical Corp.
KAL Betaine HCl+, Nutraceutical Corp.
KAL Beyond Calcium, Nutraceutical Corp.
KAL Beyond Garlic, Nutraceutical Corp.
KAL Beyond Ginkgo Biloba, Nutraceutical Corp.
KAL Beyond L 5 HTP, Nutraceutical Corp.
KAL Beyond Red Yeast Rice, Nutraceutical Corp.
KAL Beyond St. John`s Wort, Nutraceutical Corp.
KAL Beyond Vitex, Nutraceutical Corp.
KAL Bioflavonoids 1000, Nutraceutical Corp.
KAL Biotin 1000 mcg Micro Lozenge, Nutraceutical Corp.
KAL Biotin 5000 mcg, Nutraceutical Corp.
KAL Blemish Guard, Nutraceutical Corp.
KAL Blood Sugar Defense, Nutraceutical Corp.
KAL Body Defense Antioxidant, Nutraceutical Corp.
KAL Bone Defense, Nutraceutical Corp.
KAL Bone Meal Powder, Nutraceutical Corp.
KAL Bone Meal Tablets, Nutraceutical Corp.
KAL Bovine Cartilage, Nutraceutical Corp.
KAL Bromelain 1000 mg, Nutraceutical Corp.
KAL Bromelain 500 mg, Nutraceutical Corp.
KAL Bromelain Chewable, Nutraceutical Corp.
KAL C 1000 Complex, Nutraceutical Corp.
KAL C 1000 mg Bioflavonoids, Nutraceutical Corp.
KAL C 1000 mg Buffered, Nutraceutical Corp.
KAL C 1000+ Sustained Release, Nutraceutical Corp.
KAL C 1000+, Nutraceutical Corp.
KAL C 500 mg Buffered, Nutraceutical Corp.
KAL C 500+ Rose Hips & Bioflavonoids, Nutraceutical Corp.
KAL C 500+ Rose Hips, Nutraceutical Corp.
KAL C Chewable Sugarless, Nutraceutical Corp.
KAL C Chewable with Natural Food Sources, Nutraceutical Corp.
Previous
1
2
3
4
5
6
7
8
9
...
30
31
Next
General Search
Latest News
U.S. Food And Drug Administration Approves Pfizer’s INLYTA (axitinib) For Patients With Previously Treated Advanced Renal Cell Carcinoma (RCC)
Pfizer Announces FDA Acceptance Of New Drug Application For Bosutinib For Patients With Previously Treated Ph Chronic Myeloid Leukemia
FDA approves Inlyta to treat patients with a type of advanced kidney cancer
FDA Drug Safety Communication: New risk factor for Progressive Multifocal Leukoencephalopathy (PML) associated with Tysabri (natalizumab)
FDA. New and Generic Drug Approvals - January 27, 2012
Latest Drugs
Efavirenz Teva
Desloratadine Actavis
Repaglinide Accord
Emselex
Hepsera
Zulvac 1 Ovis
Zulvac 1 Bovis
Levetiracetam Sun
Inovelon
Olanzapine Glenmark Europe
Last medical tags:
Torisel
,
temsirolimus
,
Inlyta
,
chronic myeloid leukemia
,
bosutinib
,
Inlyta
,
renal cell carcinoma
,
kidney cancer
,
myelin
,
Tysabri
,
natalizumab
,
brain infection
,
progressive multifocal leukoencephalopathy
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
thoracic aortic transection
,
endovascular graft
,
methotrexate
,
Voraxaze
,
cancer chemotherapy drug
,
glucarpidase
,
Adcetris
,
bleomycin
,
multifocal leukoencephalopathy
,
CardioGen-82
,
radiation
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
FDA
,
New drugs approval 2012
,
drugs approved by FDA
,
raltegravir
,
Isentress
,
antiretroviral medicines
,
Theravance
,
Relovair
,
asthma
,
fluticasone
,
bronchitis
,
neuromuscular disease
,
SMA
,
muscle atrophy
,
Resolor
,
prokinetic
,
prucalopride
,
ADHD
,
psychiatric behavioural disorder
,
Venvanse
,
lisdexamfetamine dimesylate
,
type 2 diabetes mellitus
,
Actoplus Met XR
,
pioglitazone
,
Mylan
,
Eprosartan Mesylate Tablets
,
Teveten
,
antimicrobials
,
cephapirin
,
cephalosporin
,
teriflunomide
,
Rebif
,
alanine aminotransferase levels
,
flu-like symptoms
,
multiple sclerosis
,
electrical pulses
,
implantable pulse generator
,
Precision Plus Spinal Cord Stimulator
,
genetic blood clotting disorder
,
hemophilia A
,
Advate
,
bleeding episodes
,
heart failure
,
heart transplantation
,
Pediatric Medical Device Safety
,
pulsatile cardiac assist device
,
selective serotonin reuptake inhibitor
,
SSRI
,
pulmonary hypertension
,
» All tags
Sitemap